drugset / Trial / NCT01158703
Aspirin and Plavix Following Coronary Artery Bypass Grafting
RandomizedParallel-groupDouble-blindTreatment
Summary
The design of the study will be randomized, double blind trial, which will examine the effects of addition of clopidogrel to current guideline recommended background therapy on lowering the incidence of graft stenosis after coronary artery bypass grafting compared to placebo.
Timeline
- Start
- 2010-07
- Primary completion
- 2014-12
- Completion
- 2014-12
Outcome
Outcome not reported
Stopped (Enrollment): “poor recruitment and reduction in CT surgery support”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | 75 mg | Oral |
| Comparator | Aspirin | Small molecule | 81 mg | Oral |
Indications
No indication recorded.